Could This Clinical-Stage Biotech Stock Soar in April?
Biotech stocks are known for their wild ways. Over the last few years, for instance, we have witnessed dozens of small-cap companies soar — as well as sink — following pivotal clinical or regulatory catalysts.Perhaps one of the most intriguing aspects of this phenomenon is that the biggest moves tend to occur in under-the-radar biotechs. Before skyrocketing by over 300% […]
